Daniel Lachapelle on regulatory harmonization and global compliance
Nov 12, 2019
Global participation is the greatest advancement according to Daniel Lachapelle. Lachapelle credits the speed and ease of communication to the harmonization of the pharmaceutical regulations. He goes on to explain that CRB stays actively involved with global professional organizations which helps to efficiently manage global compliance.
Read the full roundtable discussion on regulatory harmonization and global compliance.
Originally published in Pharma’s Almanac | October 28, 2019 | PAP-Q2-NI-006 | PAP-Q2-NI-007